INT MEDICAL to Acquire Remaining 35% Stake in Pulim Medical for 31.29 Million Yuan

Stock News04-29

INT MEDICAL (01501) announced that on April 29, 2026, the company plans to acquire a 35% equity interest in Pulim Medical from Ms. Li Xiaoling, Ms. Chen Xiao, and Ms. Li Shaowei. The total consideration, including tax, amounts to 31.2853 million yuan. Upon completion of the equity acquisition, Pulim Medical will become a wholly-owned subsidiary of the company. Pulim Medical is a significant subsidiary primarily responsible for the market promotion and sales of the Group's medical devices in China. The Board of Directors believes the acquisition aligns with the company's strategic development objectives and will help enhance the Group's overall operational control and business synergy efficiency. Following the acquisition, the company will fully leverage Pulim Medical's specialized and standardized advantages in the medical device sales sector, integrate its managed projects, and continuously improve operational effectiveness to boost the company's overall sustainable development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155636810?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-29 22:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155636810","market":"sh","top_or_hot":-1,"title":"INT MEDICAL to Acquire Remaining 35% Stake in Pulim Medical for 31.29 Million Yuan","media":"Stock News","content":"<p>INT MEDICAL (01501) announced that on April 29, 2026, the company plans to acquire a 35% equity interest in Pulim Medical from Ms. Li Xiaoling, Ms. Chen Xiao, and Ms. Li Shaowei. The total consideration, including tax, amounts to 31.2853 million yuan. Upon completion of the equity acquisition, Pulim Medical will become a wholly-owned subsidiary of the company. Pulim Medical is a significant subsidiary primarily responsible for the market promotion and sales of the Group's medical devices in China. The Board of Directors believes the acquisition aligns with the company's strategic development objectives and will help enhance the Group's overall operational control and business synergy efficiency. Following the acquisition, the company will fully leverage Pulim Medical's specialized and standardized advantages in the medical device sales sector, integrate its managed projects, and continuously improve operational effectiveness to boost the company's overall sustainable development.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INT MEDICAL to Acquire Remaining 35% Stake in Pulim Medical for 31.29 Million Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINT MEDICAL to Acquire Remaining 35% Stake in Pulim Medical for 31.29 Million Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-04-29 22:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>INT MEDICAL (01501) announced that on April 29, 2026, the company plans to acquire a 35% equity interest in Pulim Medical from Ms. Li Xiaoling, Ms. Chen Xiao, and Ms. Li Shaowei. The total consideration, including tax, amounts to 31.2853 million yuan. Upon completion of the equity acquisition, Pulim Medical will become a wholly-owned subsidiary of the company. Pulim Medical is a significant subsidiary primarily responsible for the market promotion and sales of the Group's medical devices in China. The Board of Directors believes the acquisition aligns with the company's strategic development objectives and will help enhance the Group's overall operational control and business synergy efficiency. Following the acquisition, the company will fully leverage Pulim Medical's specialized and standardized advantages in the medical device sales sector, integrate its managed projects, and continuously improve operational effectiveness to boost the company's overall sustainable development.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1222","symbol_name":"医疗保健用品","start_time":0,"source_url":"","article_id":"1155636810","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155636810","pubTimestamp":1777471353,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"INT MEDICAL (01501) announced that on April 29, 2026, the company plans to acquire a 35% equity interest in Pulim Medical from Ms. Li Xiaoling, Ms. Chen Xiao, and Ms. Li Shaowei. The total...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","BK1222":"医疗保健用品","01501":"瑛泰医疗"},"translate_title":"英特医疗将以3129万元收购普利姆医疗剩余35%股权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"01501":1},"content_text":"INT MEDICAL (01501) announced that on April 29, 2026, the company plans to acquire a 35% equity interest in Pulim Medical from Ms. Li Xiaoling, Ms. Chen Xiao, and Ms. Li Shaowei. The total consideration, including tax, amounts to 31.2853 million yuan. Upon completion of the equity acquisition, Pulim Medical will become a wholly-owned subsidiary of the company. Pulim Medical is a significant subsidiary primarily responsible for the market promotion and sales of the Group's medical devices in China. The Board of Directors believes the acquisition aligns with the company's strategic development objectives and will help enhance the Group's overall operational control and business synergy efficiency. Following the acquisition, the company will fully leverage Pulim Medical's specialized and standardized advantages in the medical device sales sector, integrate its managed projects, and continuously improve operational effectiveness to boost the company's overall sustainable development.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155636810","isCrawlerRequest":true}